Terumo

Update in progress

4543.T (Tokyo)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Terumo Corporation develops and sells medical devices worldwide, organized into three segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies. Cardiac and Vascular offers catheters, guidewires, stents, coils, embolization systems, and bypass equipment. Medical Care Solutions supplies syringes, infusion pumps, IV fluids, glucose monitoring, and contract manufacturing. Blood and Cell provides blood bags and processing systems. Founded 1921; Tokyo HQ; renamed Terumo in 1974.

Company score

Sentiment: 0.81; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.69; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.16; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.23; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.52; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive